₹2448.00▲₹12.50(+0.51%)
EOD close · 3 Jul 2026
mid rallystrong hands +59
Trend and delivery agree: the price is rising and high-conviction buyers are taking delivery. Strength with substance.
52W low ₹1575.0052W high ₹2529.30
Now at 91% of its 52-week range
Long-term returns
1Y
+31.2%
3Y
+130.6%
5Y
-29.2%
Phase indicator
mid rally-3.2% from 52w high
Above 50- and 200-day MAs with +45.5% over 3 months — established uptrend.
1M
+10.1%
3M
+45.5%
1Y
+31.2%
Delivery conviction
strong handsscore +59
Delivery vs 20-day avg1.52x
Lifetime story
Gland Pharma is up 184.2% from its lifetime low of ₹861.50 on 22 May 2023. ₹10,000 invested then would be worth ₹28,416 today (39.8% CAGR over 3.1 years). Lifetime high of ₹4350.00 was set on 12 Aug 2021 (currently -43.7% below).
Fundamentals
Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.
37% cheaper than industry(Industry P/E 49.5)
| Standalone | Consolidated | |
|---|---|---|
| P/E (TTM)subs material | 31.20 | 39.47 |
| P/B | 3.76 | 3.92 |
| Price / Cash flow | 27.48 | 27.94 |
| Dividend yield | 0.81% | 0.81% |
| Book value / share | 655.31 ₹ | 627.91 ₹ |
| EPS (TTM)subs material | 78.78 ₹ | 62.28 ₹ |
Market cap
₹40.5K Cr
52W high
₹2529.30
30 Jun 2026
52W low
₹1575.00
16 Mar 2026
Returns ladder
1W
+6.2%
1M
+10.1%
3M
+45.5%
6M
+43.4%
YTD
+42.7%
1Y
+31.2%
3Y
+130.6%
5Y
-29.2%
10Y
—
Since listing
+35.0%